SJ Proctor

1.5k total citations
57 papers, 1.0k citations indexed

About

SJ Proctor is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, SJ Proctor has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 17 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in SJ Proctor's work include Hematopoietic Stem Cell Transplantation (14 papers), Lymphoma Diagnosis and Treatment (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). SJ Proctor is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Lymphoma Diagnosis and Treatment (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). SJ Proctor collaborates with scholars based in United Kingdom, Czechia and Iraq. SJ Proctor's co-authors include P. J. Hamilton, P J Carey, P Taylor, Lisbet Sviland, Jennifer Wilkinson, David W. Rowe, G Jackson, Peter G. Middleton, Michal Sieniawski and Patrick Hamilton and has published in prestigious journals such as Blood, British Journal of Cancer and Annals of Oncology.

In The Last Decade

SJ Proctor

57 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Proctor United Kingdom 19 478 256 247 233 171 57 1.0k
N Philippe France 18 456 1.0× 220 0.9× 234 0.9× 161 0.7× 266 1.6× 59 1.4k
NJ Tarbell United States 10 429 0.9× 154 0.6× 170 0.7× 135 0.6× 117 0.7× 17 764
E. S. Henderson United States 17 352 0.7× 304 1.2× 162 0.7× 193 0.8× 226 1.3× 33 909
Anna Butturini United States 17 432 0.9× 301 1.2× 373 1.5× 86 0.4× 183 1.1× 48 1.1k
Valéria Buccheri Brazil 18 471 1.0× 204 0.8× 321 1.3× 398 1.7× 234 1.4× 59 1.2k
Maurizio Musso Italy 19 702 1.5× 364 1.4× 141 0.6× 334 1.4× 243 1.4× 68 1.4k
Oumédaly Reman France 20 635 1.3× 385 1.5× 199 0.8× 362 1.6× 236 1.4× 61 1.4k
David Topolsky United States 15 337 0.7× 348 1.4× 96 0.4× 141 0.6× 93 0.5× 39 884
Jeffrey Margolis United States 18 524 1.1× 307 1.2× 103 0.4× 140 0.6× 154 0.9× 35 1.1k
R Powles United Kingdom 19 645 1.3× 258 1.0× 310 1.3× 54 0.2× 124 0.7× 52 1.1k

Countries citing papers authored by SJ Proctor

Since Specialization
Citations

This map shows the geographic impact of SJ Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Proctor more than expected).

Fields of papers citing papers by SJ Proctor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Proctor. The network helps show where SJ Proctor may publish in the future.

Co-authorship network of co-authors of SJ Proctor

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Proctor. A scholar is included among the top collaborators of SJ Proctor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Proctor. SJ Proctor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Proctor, SJ, Jennifer Wilkinson, & Michal Sieniawski. (2009). Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future. Critical Reviews in Oncology/Hematology. 71(3). 222–232. 34 indexed citations
2.
Jones, Gail, Penelope R. A. Taylor, Kevin Windebank, et al.. (2007). Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents. British Journal of Cancer. 97(1). 29–36. 2 indexed citations
3.
Proctor, SJ & Jennifer Wilkinson. (2006). A web-based study concept designed to progress clinical research for ‘orphan’ disease areas in haematological oncology in the elderly: The SHIELD programme. Critical Reviews in Oncology/Hematology. 61(1). 79–83. 8 indexed citations
5.
Fitzgerald, James, et al.. (2001). Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfusion Medicine. 11(6). 455–458. 15 indexed citations
6.
Cavet, Jim, Anne Lennard, A. Gascoigne, et al.. (2000). Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplantation. 25(5). 571–573. 14 indexed citations
7.
Galloway, M J, et al.. (1999). Implementing clinical governance in the united kingdom: the role of a regional haematology group. British Journal of Haematology. 107(4). 680–684. 3 indexed citations
9.
Hromadníková, Ilona, Lisbet Sviland, P Taylor, et al.. (1999). Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants – effect of GVHD prophylaxis. Bone Marrow Transplantation. 24(8). 857–863. 18 indexed citations
10.
11.
Chapman, Claire, et al.. (1997). Umbilical cord blood collection and separation for haematopoietic progenitor cell banking. Bone Marrow Transplantation. 19(10). 1023–1028. 53 indexed citations
12.
Dickinson, Anne M., et al.. (1995). Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.. PubMed. 9(3). 444–9. 5 indexed citations
13.
Carey, Peter, et al.. (1994). Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. British Journal of Cancer. 70(3). 501–505. 13 indexed citations
14.
Jackson, G, et al.. (1993). Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. British Journal of Cancer. 67(2). 383–387. 23 indexed citations
15.
Proctor, SJ, et al.. (1993). Classical staging of Hodgkin's disease is inappropriate for selecting patients for clinical trials of intensive therapy: the case for the objective use of prognostic factor information in addition to classical staging.. PubMed. 7(11). 1911–4; discussion 1917, 1919. 7 indexed citations
16.
Dickinson, Anne M., Elizabeth A. Jacobs, Ian Williamson, M M Reid, & SJ Proctor. (1988). Suppression of human granulocyte-macrophage colony formation in vitro by natural killer cells. Clinical Immunology and Immunopathology. 49(1). 83–90. 1 indexed citations
17.
Sviland, Lisbet, Andrew Robinson, SJ Proctor, & D. Nicholas Bateman. (1987). Interaction of cimetidine with oral melphalan. Cancer Chemotherapy and Pharmacology. 20(2). 173–5. 14 indexed citations
18.
Proctor, SJ, et al.. (1984). Hyperviscosity syndrome in IgE myeloma.. BMJ. 289(6452). 1112–1112. 9 indexed citations
19.
Proctor, SJ, et al.. (1982). Autoantibody synthesis by thyroid lymphocytes. Annales d Endocrinologie. 4 indexed citations
20.
Proctor, SJ, et al.. (1981). Terminal deoxynucleotidyl transferase activity in childhood and adult acute lymphoblastic leukaemia.. Journal of Clinical Pathology. 34(8). 892–895. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026